Skip to main content

and
  1. No Access

    Chapter

    Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities

    In order to improve the early detection and diagnosis of cancer, give more accurate prognoses, stratify individuals by risk, predict response to treatment, and help the transition of basic research into clinic...

    Barbara K. Dunn, Karin Jegalian, Peter Greenwald in Clinical Cancer Prevention (2011)